Andrew J. Cowan
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa(ZA)Oregon Health & Science University(US)University of Washington(US)University of Washington Medical Center(US)Fred Hutch Cancer Center(US)Cancer Consortium(US)University of Washington Applied Physics Laboratory(US)Seattle University(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Protein Degradation and Inhibitors, Lymphoma Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Diagnosis and Management of Multiple Myeloma(2022)922 cited
- → Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial(2020)660 cited
- → Global Burden of Multiple Myeloma(2018)611 cited
- → γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma(2019)314 cited
- → Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies(2020)206 cited
- → Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial(2023)146 cited